Intracavitary treatment of transitional cell carcinoma of the bladder: questions and lessons after 27 years of experience.
Kurth
K H
KH
Department of Urology, University of Amsterdam, The Netherlands.
Sylvester
R
R
de Pauw
M
M
ten Kate
F
F
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000188:drug therapy; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D006801:Humans; D009361:Neoplasm Invasiveness; D011379:Prognosis; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents